Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Tolerability of Zolpidem in the Treatment of Children Aged 6 to 17 Years With ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study

NCT00318448 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00318448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00318448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Tolerability of Zolpidem in the Treatment of Children Aged 6 to 17 Years With ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
August 31, 2006
Enrollment
201 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder